Cancers, Volume 16, Issue 22
2024 November-2 - 169 articles
Cover Story: Brain metastases are common in lung cancer, posing distinct clinical challenges. Advances in radiation and systemic therapies underscore the need for an improved integration of multidisciplinary approaches to optimize both survival and symptomatic burden. Radiotherapy prioritizing durable control with minimal neurocognitive toxicity, as well as systemic agents with central nervous system activity, can be leveraged to deliver increasingly personalized regimens. Clinical trials are ongoing to elucidate how to integrate clinical features, tumor biology, and predictive biomarkers to effectively downstage intracranial disease and consolidate persistent metastases. Further work is needed to design risk-adapted strategies to balance intracranial efficacy with patient values while preserving neurocognitive. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.